Answers are grounded in this paper and cite their sources.
This retrospective traces the evolution of our understanding of the phosphatidylinositol transfer protein (PITP) family over the past fifty years, beginning with its purification. I summarise the early identification of PITPs as phosphatidylinositol/phosphatidylcholine (PI/PC) transfer proteins and describe how the conserved PITP domain was subsequently recognised in five mammalian proteins, occurring either as a single domain or within a multi-domain architecture. Parallel genetic studies in Drosophila led to the discovery of RdgB, a retinal degeneration mutant protein containing a PITP domain. Later work revealed that some members of the PITP family members mediate PI/PA (phosphatidate) exchange enabling the reciprocal transfer of PA and PI during phospholipase C (PLC) signalling. PITPs thus function as key lipid exchangers, delivering PI for synthesis of phosphorylated derivatives including phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P 2 ) across cellular compartments. These activities position PITPs at the core of fundamental processes such as PLC signalling and Golgi membrane trafficking, where phosphoinositides play central regulatory roles. Finally, I highlight how PITPs have emerged as critical factors in diverse physiological processes and as contributors to a growing range of pathological conditions. • PITPs are conserved lipid transfer proteins essential for phosphoinositide homeostasis. • Class I and Class II PITPs sustain PLC signalling through distinct PI delivery mechanisms. • PITPs support Golgi function, vesicle trafficking and membrane remodelling in multiple cell types. • PITPs influence development, immunity, metabolism, cancer and viral replication, highlighting therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Shamshad Cockcroft (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: